ENHYPEN Announces 4th World Tour 'ENHYPEN WORLD TOUR 'BLOOD SAGA''! Visiting 21 Cities Worldwide Starting with Seoul in May

(P)&(C) BELIFT LAB Inc.

The global group ENHYPEN has announced their fourth world tour, 'ENHYPEN WORLD TOUR 'BLOOD SAGA'' (hereinafter referred to as 'BLOOD SAGA'). 'BLOOD SAGA' will visit 21 cities around the world, starting with performances in Seoul, South Korea, from May 1st to 3rd.

In Japan, eight performances are scheduled across four cities: Tokyo (December 1st and 2nd), Aichi (December 26th and 27th), Fukuoka (February 6th and 7th), and Osaka (February 19th and 20th). Details regarding the performance venues and ticket sales schedule will be announced at a later date.

In April 2025, ENHYPEN earned the title of "Performance Kings" at the Coachella Valley Music and Arts Festival, one of the largest music festivals in the United States. They have demonstrated a strong presence in physical album sales, achieving their first triple-million seller with their 2nd Studio Album 'ROMANCE : UNTOLD' and their third double-million seller with their 6th Mini Album 'DESIRE : UNLEASH.' The scale of their tours is also expanding rapidly; their third world tour, 'ENHYPEN WORLD TOUR ‘WALK THE LINE’,' mobilized approximately 676,000 people, marking their largest world tour to date. Notably, they boast the status of "performance powerhouses," having achieved the fastest three-city dome tour in Japan for a K-POP boy group since debut, and the fastest stadium performance in Japan for an overseas artist (4 years and 7 months after debut). Showing explosive growth, ENHYPEN has won five grand prize trophies at major music awards ceremonies, including the MAMA AWARDS, from 2025 to the present, establishing a firm position as new leaders spearheading K-POP.

In January of this year, they made a comeback with their 7th Mini Album 'THE SIN : VANISH,' achieving their fourth double-million seller and continuing to steadily update their career highs, garnering significant attention from around the world.

Please look forward to 'BLOOD SAGA,' where you can see a new side of ENHYPEN!

【'ENHYPEN WORLD TOUR 'BLOOD SAGA'' Japan Performance Overview (Tentative)】 [Tokyo] December 1 (Tue), 2 (Wed), 2026 [Aichi] December 26 (Sat), 27 (Sun), 2026 [Fukuoka] February 6 (Sat), 7 (Sun), 2027 [Osaka] February 19 (Fri), 20 (Sat), 2027 ※ Details regarding the performances will be announced at a later date. ※ Please note that the ENHYPEN JAPAN OFFICIAL SITE management office cannot answer any inquiries regarding matters other than those listed above.

(P)&(C) BELIFT LAB Inc.

●ENHYPEN PROFILE A six-member global group consisting of JUNGWON, JAY, JAKE, SUNGHOON, SUNOO, and NI-KI. Born from Mnet's massive project 'I-LAND,' the group name embodies the meaning that, just as a hyphen (-) connects, different boys "connect" to find each other and grow together, with the intention of "connecting" people to people and world to world through music.

Since their debut in November 2020, ENHYPEN has been loved around the world for their overwhelming conceptual expressiveness and has shown growth with every album. Their 2nd Studio Album 'ROMANCE : UNTOLD,' released in July 2024, became their first triple-million seller. Their third world tour, 'WALK THE LINE,' held from October 2024 to October 2025, successfully concluded as their largest world tour to date, mobilizing over 676,000 people across 32 performances in 19 cities at large-scale venues such as domes and stadiums. Notably, they boast the status of "performance powerhouses," having achieved the fastest three-city dome tour in Japan for a K-POP boy group since debut, and the fastest stadium performance in Japan for an overseas artist (4 years and 7 months after debut). Their Japanese 4th single 'YOI,' released the following July, earned their first "Triple Platinum" certification from the Recording Industry Association of Japan in October. Their 7th Mini Album 'THE SIN : VANISH,' released on January 16th of this year, became their fourth double-million seller, as they continue to update their career highs.